# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst Vik Chopra maintains Alphatec Holdings (NASDAQ:ATEC) with a Overweight and raises the price target from ...
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a ...
Barclays analyst Matt Miksic maintains Alphatec Holdings (NASDAQ:ATEC) with a Overweight and raises the price target from $2...
Canaccord Genuity analyst Caitlin Cronin maintains Alphatec Holdings (NASDAQ:ATEC) with a Buy and maintains $20 price target.
Alphatec Holdings (NASDAQ:ATEC) raises FY2025 sales outlook from $734.000 million to $742.000 million vs $734.219 million estim...